All Rights Reserved. Do you know what people like you are earning?
© 2020 Aisling Capital. T (212) 651-6380; F (212) 651-6379; If you are a human and are seeing this field, please leave it blank. Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies.A combined 150+ years of experience in the healthcare industry.$1.8 billion in assets, with a track record of investing and returning capital since 2000.Aisling congratulates the management team of Loxo on its recent acquisition by Eli Lilly.Aisling congratulates the management team of Zeltiq on its recent acquisition by Allergan.Agreement outlines commercialization and distribution execution strategy upon FDA approval EVERSANA to provide commercial services of approximately $250 million over 5 years FREMONT, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage…XENLETA represents the first new antibiotic class approved for patients with CAP in Europe in nearly 20 years XENLETA approval provides urgently needed short-course, empiric monotherapy treatment option for CAP aligned with…- $32.5M Series A Financing Led by Aisling Capital, Vertex Ventures HC, Qiming Venture Partners USA, Driehaus Capital Management, and BVF Partners - - Registration-Enabling Phase 2 CRESTONE Study Now… 8,529 company reviews and salaries posted anonymously by employees. Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. We would like to show you a description here but the site won’t allow us. Since 2000, Aisling Capital has raised over $1.8 billion in committed capital across four funds. A free inside look at capital Aisling reviews for 0 companies. Stop guessing.Understand what's truly driving the gender pay gap.How the salary history question affects pay equity.Improve your chances of receiving a raise when you ask.Help us gather more data! Best Cities for Jobs 2020 NEW! Meet Our Team A combined 150+ years of experience in the healthcare industry.
Aisling Capital invests in both private and public companies utilizing a wide variety of investment structures. The firm seeks to invest in the technology, bio-pharma, consumer, diagnostics, medical device, service, and life-sciences sectors. Designed by Aisling Capital General Information Description. The completion of the human genome has given scientists new insights into the causes of human disease. Prior to Aisling, Dr. Aguiar was a partner at Thomas, McNerney and Partners, a $600 million healthcare-focused venture capital and growth equity fund, from 2007 to 2015. Aisling Capital is a leading investment firm that invests in products, technologies, and global businesses that advance health. In addition to investing in companies developing pharmaceutical, biotechnology and medical products, Aisling invests in businesses that provide drug development, manufacturing and other important services to the healthcare industry. Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology.
Aisling Capital invests in products, technologies and businesses that advance health. Home; About; Dr. Aguiar was a Managing Director of HealthCare Ventures, a healthcare venture capital fund, from 2001 to 2007. 888 Seventh Avenue 12th Floor New York, NY 10106. To learn more about aisling capital and our funds or to provide us with information on an investment opportunity, please contact: Aisling Capital. Find out what you're worth.Use our tool to get a personalized report on your market worth.Find your market worth with a report tailored to youCompanies in the same industry as Aisling Capital, ranked by salary.What your skills are worth in the job market is constantly changing.Tell us about your job and pay factors like skills and educationFind your market worth with a report tailored to you Jobs Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies. Founded in 2000, Aisling Capital is a venture capital investment firm that is based in New York, New York. Click here for directions.